Sex Differences and Drug Dose Influence the Role of the α7 Nicotinic Acetylcholine Receptor in the Mouse Dextran Sodium Sulfate-Induced Colitis Model

Nicotine Tob Res. 2017 Apr 1;19(4):460-468. doi: 10.1093/ntr/ntw245.

Abstract

Introduction: α7 nicotinic acetylcholine receptors (nAChRs) play an important role in vagus nerve-based cholinergic anti-inflammatory effects. This study was designed to assess the role of α7 nAChRs in dextran sodium sulfate (DSS)-induced colitis in male and female mouse. We first compared disease activity and pathogenesis of colitis in α7 knockout and wild-type mice. We then evaluated the effect of several α7 direct and indirect agonists on the severity of disease in the DSS-induced colitis.

Methods: Male and female adult mice were administered 2.5% DSS solution freely in the drinking water for 7 consecutive days and the colitis severity (disease activity index) was evaluated as well as colon length, colon histology, and levels of tumor necrosis factor-alpha colonic levels.

Results: Male, but not female, α7 knockout mice displayed a significantly increased colitis severity and higher tumor necrosis factor-alpha levels as compared with their littermate wild-type mice. Moreover, pretreatment with selective α7 ligands PHA-543613, choline, and PNU-120596 decreased colitis severity in male but not female mice. The anti-colitis effects of these α7 compounds dissipated when administered at higher doses.

Conclusions: Our results suggest the presence of a α7-dependent anti-colitis endogenous tone in male mice. Finally, our results show for the first time that female mice are less sensitive to the anti-colitis activity of α7 agonists. Ovarian hormones may play a key role in the sex difference effect of α7 nAChRs modulation of colitis in the mouse.

Implications: Our collective results suggest that targeting α7 nAChRs could represent a viable therapeutic approach for intestinal inflammation diseases such as ulcerative colitis with the consideration of sex differences.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / administration & dosage
  • Anti-Inflammatory Agents* / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Colitis* / chemically induced
  • Colitis* / genetics
  • Colitis* / metabolism
  • Dextran Sulfate / adverse effects*
  • Disease Models, Animal
  • Female
  • Inflammation / genetics
  • Isoxazoles / administration & dosage
  • Isoxazoles / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Phenylurea Compounds / administration & dosage
  • Phenylurea Compounds / pharmacology
  • Quinuclidines / administration & dosage
  • Quinuclidines / pharmacology
  • alpha7 Nicotinic Acetylcholine Receptor* / genetics
  • alpha7 Nicotinic Acetylcholine Receptor* / metabolism

Substances

  • 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea
  • Anti-Inflammatory Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Isoxazoles
  • N-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide
  • Phenylurea Compounds
  • Quinuclidines
  • alpha7 Nicotinic Acetylcholine Receptor
  • Dextran Sulfate